Pumilio (Pum) is a key component of neuron firing-rate homeostasis that maintains stability of neural circuit activity. Whilst Pum is ubiquitously expressed, we understand little about how synaptic excitation regulates its expression. Here, we characterised the Drosophila dpum promoter and identified multiple Myocyte enhancer factor-2 (Mef2)-binding elements. To understand the transactivation capability of dMef2, we cloned 12 dmef2 splice variants and used a luciferase-based assay to monitor dpum promoter activity. Whilst all 12 dMef2 splice variants enhance dpum promoter activity, exon 10-containing variants induce greater transactivation. Previous work shows dPum expression increases with synaptic excitation. However, we observe no change in dmef2 transcript in CNS exposed to picrotoxin (PTX). The lack of activity-dependence is indicative of additional regulation. We identified p300 as a likely candidate. We show that by binding to dMef2, p300 represses dpum transactivation. Significantly, p300 transcript is down-regulated by enhanced synaptic excitation (PTX) which, in turn, increases transcription of dpum through derepression of dMef2. These results suggest the activity-dependent expression of dpum is regulated by an interaction between p300 and dMef2.
Introduction
Pumilio (Pum), a founding member of the Pum/FBF (Puf) RNA-binding protein family, is central to multiple aspects of CNS function, including (but not limited to) firing-rate homeostasis, dendritic morphogenesis, synaptic growth and function, expression of acetylcholinesterase and long-term memory (Chen et al., 2008 , Driscoll et al., 2013 , Menon et al., 2004 , Muraro et al., 2008 , Vessey et al., 2010 . Despite a wide-ranging involvement in many aspects of CNS function, little is understood concerning the regulation of Pum expression in the CNS. Importantly, reduced levels of Pum have been linked to epilepsy in Drosophila, rodents and human (Follwaczny et al., 2017 , Lin et al., 2017 , Siemen et al., 2011 , Wu et al., 2015 .
The number of transcripts expressing PREs is indicative of the importance of Pum. Despite this, however, our understanding of pum expression and role(s) is limited and, where information is known, is mostly focused on post-transcriptional modification. For example, the dpum transcript is itself regulated through translational repression by the cytoplasmic RNA-Binding Fox protein (Rbfox1, aka A2BP1) in order to promote germ cell development (Carreira-Rosario et al., 2016) . In mammals, Myocyte Enhancer Factor-2 (Mef2) regulates expression of miR-134 which, in turn, downregulates pum2 transcript to fine tune dendrite morphogenesis (Fiore et al., 2009 , Fiore et al., 2014 . Mef2 is an activity-dependent transcription factor that has been implicated to control synapse formation in addition to dendrite morphogenesis (Flavell et al., 2006) . Depending on interaction with either positive or negative cofactors, Mef2 can potentiate or repress gene transcription. Through an interaction with GATA4, a cardiac-enriched transcription factor, Mef2 activates the Nppa promoter to regulate cardiac development (Morin et al., 2000) . In contrast, Mef2 forms a complex with class II histone deacetylases (HDACs) to repress gene transcription by deacetylating histones, resulting in chromatin condensation and a reduced accessibility of core transcriptional machinery to promoter region of target genes (Kao et al., 2001 , Lu et al., 2000 , McKinsey et al., 2001 ).
To identify how transcription of pum is regulated, we cloned the promoter region of dpum and identified putative binding motifs for 114 transcription factors, including multiple dMef2 elements. A luciferase-based reporter, driven by the dpum promoter, shows that dMef2 is sufficient to transactivate the dpum promoter. Magnitude of transactivation varies across the many dMef2 splice-variants present in CNS. Significantly, we also report that dMef2 mediated transactivation of dpum is repressed by p300 (aka Nejire), a histone acetyltransferase (HAT). Unlike dMef2, we show that p300 expression is directly regulated by neuronal activity and, thus, provide a potential route through which membrane depolarization regulates expression level of dpum.
Results

Identification of the pumilio promoter region
To understand transcriptional regulation of dpum, we identified the dpum promoter region. A 2-kb region upstream of the transcription start site was targeted as a potential location. Interrogation of transcription factor databases (TRANSFAC model, MAPPER) (Marinescu et al., 2005) , identified putative binding motifs for 114 transcription factors within the region -2000 to +1 (transcription initiation marked as +1, motifs listed in Table EV1 ). Putative transcriptional binding motifs include: Sp1, TBP, C/EBP, Oct-1, Mef2, MADS-A/B, Hb, NF-kappaB, TCF, CREB and SRF (Fig.  EV1) . To test for function of the dpum promoter region, the 2-kb fragment, (-2000 to +1, termed pumA) was placed upstream of firefly-luciferase (FF) and transiently transfected in S2R+ cells. After 24 h pumA:FF resulted in a 156.5 ± 21.9-fold increase in FF activity compared to transfection of cells with empty vector (set at 1, Fig. 1 , p = 2.5x10 -7 ).
To evaluate the minimal promoter region of dpum, we generated a series of deletion constructs in addition to pumA: pumB (-1434 to +1), pumC (-578 to +1), pumD (-312 to +1) and pumE (-189 to +1) (Fig. 1 ). Compared to pumA:FF, pumB:FF and pumC:FF resulted in a similar increase in FF expression (164.8 ± 13.7 and 159.8 ± 17.2-fold, p = 4x10 -9 and 3.2x10 -8 , respectively), whilst pumD:FF and pumE:FF showed a lower, but still significant, increase (103 ± 11.1 and 72.5 ± 13.4-fold increase, p = 3.2x10 -8 and 2.2x10 -6 , respectively) ( Fig. 1) . Thus, it would seem that multiple elements contained within the 2-kb region are capable of increasing dpum expression.
dMef2 transactivates the pumilio promoter
Mef2 is reported to reduce pum2 transcript post-transcriptionally through increased expression of miR-134 (Fiore et al., 2009) . However, our analysis of the 2-kb dpum promoter identified four putative Mef2 binding sites with the consensus sequence (C/T)T(A/T)(A/T)AAATA(A/G) (Gossett et al., 1989) (Fig. 1 ). These four Mef2 elements (termed , are located at -1561, -423, -298 and -214bp, respectively (Fig. 1 ). This high number of sites is indicative of direct regulatory effect. To test if dpum expression is regulated by Mef2, we used Drosophila mef2 (dmef2) dsRNA (specific for all variants) to knockdown endogenous expression in S2R+ cells that co-expressed the pumA:FF reporter. This was sufficient to reduce pumA promoter activity (154.5 ± 13.1 vs. 113.2 ± 15.1 control vs. dmef2 dsRNA, p = 0.006) indicative that dpum expression is endogenously regulated by dMef2.
Dmef2 is encoded by a single gene (Lilly et al., 1994 , Nguyen et al., 1994 , Taylor et al., 1995 and contains 15 exons. Exons 10 and 14 are alternatively spliced, while exons 9 and 15 contain cryptic splice sites and generate cassettes 9A and 15A, respectively ( Fig. 2A) . To determine the most common splice isoforms of dmef2 transcripts present in CNS of 3 rd instar Drosophila larvae, RT-PCR was used to isolate and clone 56 complete open reading frames (ORFs). Comparison of exon composition of clones revealed 9 unique splice variants. Isoforms dmef2(I-IV) were previously identified (Gunthorpe et al., 1999 , Taylor et al., 1995 , whilst dmef2(V-VIII) and dmef2(mini) are novel. Analysis of the 56 ORFs showed that dmef2(II) and dmef2(VI) are present at highest frequency ( Fig. 2A) . Analysis of exon usage across all splice sites show that exon 10 is present at highest abundance followed by exon 14 (Fig. 2B ).
To have a better understanding of the ability of individual dMef2 splice variants to transactivate pumA:FF activity, we constructed another 3 splice variants (although not found in our CNS analysis, these variants are theoretically possible), dmef2(IX-XI) ( Fig. 2A) . Expression of individual dmef2 variants, in S2R+ cells, resulted in a 1.6 ± 0.1 to 3.3 ± 0.2-fold increase in FF expression compared to control (no dmef2 expression, set at 1) (Fig. 3A) . Sorting splice variants by fold change formed a clear cluster containing exon 10 (Fig. 3B ). Exon 10 is contained within dmef2 (I, II, III, IV, VI and VII) that, collectively, transactivated the dpum promoter to a greater level than variants lacking this exon: dmef2 (V, VIII, IX, X, XI and mini) . To further confirm dMef2 transactivation of dpum, we compared FF activity of each dpum promoter construct (pumA to E) following dmef2(VII) overexpression (the variant showing the strongest transactivation). Promoter fragments pumA-E contain 4, 3, 3, 2 and 0 predicted Mef2 binding elements, respectively (Fig. 1) . Overexpression of dmef2 resulted in 1.9 ± 0.3, 1.7 ± 0.1, 1.4 ± 0.3 and 1.4 ± 0.3-fold increase in promoter activity (pumA-D, p = 1.2x10 -6 , 4.1x10 -6 , 0.004, 0.05 respectively) compared to control (no dmef2 expression, set at 1), whilst pumE (lacking an Mef2 binding motif) showed no change (1.2 ± 0.1, p > 0.05) (Fig. 4A ).
dMef2 regulates Pumilio expression level
To confirm our observations of transcriptional regulation of dpum by dMef2, we determined effect to dPum protein level. Because of the poor performance of commercially-available anti-Pum antibodies for Western Blotting in Drosophila (our unpublished data), we previously developed a monitor of dPum protein activity (Lin et al., 2017) . Essentially, we constructed an actin promoter driven firefly-luciferase reporter gene (FF-PRE), containing PREs, (Pumilio Response Elements) in the 3' UTR. Increased dPum is sufficient, through binding the PREs and inhibiting translation, to reduce FF activity. An identical renilla-luciferase (Ren) reporter, but lacking the PRE sites (and thus not affected by dPum), is co-expressed to allow ratiometric determination of activity (to compensate for batch differences between construct expression). Overexpression of dmef2(VI) or dmef2(VII) isoforms in S2R+ cells, that express both reporters, significantly reduces the ratio of FF-PRE/Ren to 0.7 ± 0.04 and 0.7 ± 0.21, respectively, (control, no dmef2 expression, set as 1, p = 0.00013 and 0.03, respectively, Fig. 4B ). We conclude that increasing dmef2 is sufficient to increase dPum protein, in addition to transcript abundance.
p300 supresses dMef2-mediated pumilio transactivation
Our prior work has shown levels of dPum and Pum2 (in fly and rat, respectively) are sensitive to neuronal activity: increasing as levels of synaptic excitation increase (Driscoll et al., 2013 , Mee et al., 2004 . It was expected, therefore, that dmef2 would show activity-dependent transcription. Similar to mammals, ingestion of the proconvulsant picrotoxin (PTX) by larvae is sufficient to increase synaptic excitation and induce a seizure-like state (Stilwell et al., 2006) . Therefore, we performed RTqPCR to examine dmef2 transcript expression in CNS taken from PTX-fed larvae. We did not, however, observe a significant fold-change (0.97 ± 0.06, n = 5, p > 0.05) compared to vehicle control (set at 1). This lack of effect is indicative that expression of dmef2, in Drosophila, is not activity-dependent. Moreover, if dMef2 regulates transcription of dpum, this would likely be through additional, and activity-dependent, regulators. p300 is a reported co-regulator of Mef2A in mammal (De Luca et al., 2003) and we identify potential binding sites (GGGAG) for this protein in the dpum promoter (Chen & Hung, 1997 , Rikitake & Moran, 1992 , (see Fig. 1 ). A previous RNA-seq analysis, between isolated CNS taken from wildtype (WT) larvae and WT larvae fed PTX, identified Drosophila p300 to be significantly down-regulated by enhanced synaptic excitation (214 ± 10 vs 163 ± 2 counts per million, WT vs. WT fed PTX, n = 3, p = 0.001) (Lin et al., 2017) . To confirm this observation, we performed RT-qPCR to examine p300 transcript abundance in CNS taken from PTX-fed WT larvae: p300 transcript expression is downregulated to 0.87 ± 0.04 (n = 5, p = 0.0026) compared to vehicle control (set at 1).
To test how p300 contributes to transcriptional regulation of dpum expression, we coexpressed p300 and pumA:FF in S2R+ cells. Overexpression of p300 was sufficient to reduce pumA promoter activity to 0.76 ± 0.07, (pumA:FF alone set at 1, n = 5, p = 0.005). Moreover, dMef2-mediated activation of pumA:FF is abolished when coexpressed with p300 (0.75 ± 0.04, n = 5, p = 0.0034) (Fig. 5A ). Co-transfection with varied doses of p300 showed a clear dose-dependent suppression of dMef2-mediated transactivation (2.79 ± 0.22, 1.8 ± 0.17, 1.53 ± 0.03, 1.19 ± 0.05 and 0.76 ± 0.07, p300 plasmid: 0, 10, 20, 50 and 100 ng, respectively, p = 4.2x10 -15 ) (Fig. 5B) . Pretreatment of S2R+ cells with p300 dsRNA enhanced pumA:FF promoter activity to 2.12 ± 0.22 (n = 5, p = 0.0001) (Fig. 5A) . Finally, overexpression of dmef2, in the presence of p300 dsRNA, further increased pumA:FF activity to 4.41 ± 0.74 (n = 5, p = 0.0001) (Fig. 5A) . Collectively, these data suggest that p300 negatively regulates the dpum promoter. However, it does not discriminate whether p300 acts through direct binding to the dpum promoter.
To test whether binding of p300 to the dpum promoter is required for repression of dMef2-dependent dpum transactivation, we expressed p300 and dmef2 with pumC:FF, which lacks consensus p300 binding sequences (see Fig. 1 ). Whilst expression of dMef2 enhanced pumC:FF activity (2.41 ± 0.2, pumC:FF alone set at 1, n = 5, p = 1.4x10 -6 ), co-expression of p300, however, was still sufficient to significantly reduce dMef2-mediated transactivation (1.0 ± 0.1, n = 5, p > 0.05, Fig. 5C ). Thus, direct binding of p300 to the dpum promoter is seemingly not required for repression of dMef2-mediated dpum transactivation, indicative of a protein-protein interaction between p300 and dMef2. To demonstrate a physical interaction between p300 and dMef2, we performed a yeast two-hybrid assay. The bait plasmid pGBKT7-p300 (BD-p300) and the prey pGADT7-dmef2 (AD-dmef2(VI) or AD-dmef2(VII)) were cotransformed into a Y2HGold yeast strain. Co-expression of BD-p300 with ADdMef2(VI) or AD-dMef2(VII) resulted in activation of all four GAL4-responsive markers, HIS3, ADE2, AUR1-C and MEL1 reporters in Y2HGold. Conversely, coexpression of control groups, BD-p300/AD-T (large T antigen) or AD-dMef2/BDLam (Lamin C), was not able to activate reporter gene expression, indicative that the auto-activation of BD-p300 and AD-dMef2 were negligible (Fig. 5D ). This result strongly suggests that p300 directly binds dMef2.
p300 represses pumilio promoter activity in vivo
To test dpum promoter activity in vivo, we generated a transgenic pumC-GAL4 fly and mated it with UAS-luciferase (UAS-luc) (Markstein et al., 2008) . The resultant 3 rd instar larvae, expressing pumC-GAL4>luc showed a significant increase (2.1 ± 0.2-fold) in luc activity compared to control (UAS-luc line, set at 1, p = 1.3x10 -5 , t-test, n = 10). To test how the pumC promoter responds to increased synaptic excitation, we established a stable line of pumC-GAL4>luc and raised larvae on food containing PTX (1 µg/ml). This resulted in a 1.7 ± 0.4-fold increase in luc compared to vehicle control (i.e. no PTX, set at 1, p = 0.003, n = 10, t-test). This result not only confirms our previous observations that dpum expression is regulated by membrane depolarization (Mee et al., 2004) , but transfers our capability to measure dpum promoter activity to in vivo.
Overexpression of dmef2, by crossing pumC-GAL4>luc with UAS-dmef2, resulted in a 2.0 ± 0.3-fold increase in luc expression compared to pumC-GAL4>luc crossed with control UAS-GFP (set at 1, p = 0.0005, n = 10, Fig. 6 ). This confirms that the pumC promoter is transactivated by dMef2 in vivo. To validate our observation that p300 represses dpum expression, we crossed pumC-GAL4>luc with UAS-p300 or UASp300
RNAi . Overexpression of p300 resulted in a 0.4 ± 0.2-fold reduction in luc activity (p = 0.0005, n = 10), whilst p300-knockdown increased luc expression by 1.3 ± 0.4-fold (p = 0.02, n = 10) (Fig. 6 ). p300 contains histone acetyltransferase (HAT) activity (Ogryzko et al., 1996) . To test if HAT activity is required for the repression of dpum transactivation, we crossed pumC-GAL4>luc with UAS-p300
F2161A
, a mutant with an abolished HAT activity (Ludlam et al., 2002) . Overexpression of p300 F2161A still resulted in a 0.3 ± 0.1-fold reduction in luc activity (p = 0.0003, n = 10) (Fig. 6 ), indicating that p300-dependent repression of dpum expression is independent of HAT activity. Thus, we validate in vivo that dMef2 is sufficient to transactivate the dpum promoter and that this activity is negatively regulated by p300.
Discussion
Pum is a key regulator of neuronal firing-rate homeostasis that maintains action potential firing within physiologically-appropriate limits , Mee et al., 2004 , Muraro et al., 2008 . Despite this critical role, little is known concerning how Pum levels are regulated. Its involvement with homeostasis suggests that pum transcription will be governed by an activity-dependent process (Mee et al., 2004) . In this study, we characterised the dpum promoter region and identified both Mef2 and p300 to be part of an activity-dependent regulatory mechanism. The complete regulatory mechanism is, however, likely to be more complicated based on our identification of binding motifs for 114 putative transcription factors within a 2-kb region upstream of the dpum transcription start site. A series of deletion constructs show that pumA, pumB and pumC promoters (compose of 2000, 1434 and 578 nucleotides, respectively) exhibit promotor activity, whilst pumD and pumE (consist of 312 and 189 nucleotides, respectively) result in a reduced, but still significant, activity. The pumE promoter, the shortest construct we tested, contains binding motifs for 15 transcription factors (e.g., Pbx-1, BR-C Z4, Zen and Lhx3a) and is, as we show, still capable of driving FF expression in S2R+ cells. Further truncations will be required to identify the minimal promoter region for dpum.
Multiple dMef2 binding motifs are located within the 2-kb dpum promoter region and manipulating dmef2 expression is sufficient to influence promoter activity. This strongly suggests that dpum expression is regulated, at least in part, by dMef2. Dmef2, which is encoded by a single gene, contains 15 exons. Of these exons, 4 are subject to alternative splicing and generate at least 12 splice variants (dmef2(I-XI) and dmef2(mini)). All splice isoforms transactivate the dpum promoter and, notably, exon 10 containing isoforms result in greater activation compared to variants lacking this exon. This differential activity may be indicative that the level of dpum transactivation can be fine-tuned through altering of dMef2 isoform expression. In muscle, however, it is the expression level of dMef2, rather than isoform expression, which is seemingly more important for cellular differentiation (Gunthorpe et al., 1999) . This conclusion was reached, however, without consideration of exon 10 lacking isoforms, because splicing of exon 10 was not previously observed (Gunthorpe et al., 1999 , Taylor et al., 1995 . Our bioinformatics shows that Mef2 binding sites are also conserved in the mammalian (e.g. human and mouse) pum2 promoter region. Interrogation using the Harmonizome search engine followed by ChIP-X enrichment analysis (ChEA) of transcription factor targets database, identifies 23 transcription factors, including p300 and Mef2A, associate with the pum2 promoter region (Lachmann et al., 2010 , Rouillard et al., 2016 . A genome-wide tiling array (ChIP-Chip) analysis similarly identifies dpum as a target of dMef2 (Sivachenko et al., 2013) . Our analysis of the promoter region (-2000 to +1, set transcription initiation at +1), in both mouse and human pum2, identifies 5 and 6 Mef2 elements, respectively (Table EV2 and EV3). Thus, it seems highly likely that Mef2 is a direct regulator of pum transcription in both insects and mammals. This extends the activity of this transcription factor in addition to its reported inhibitory control of pum2 transcript abundance via up-regulation of miR-134 (Fiore et al., 2009 , Fiore et al., 2014 . It will be important to understand the relative efficacy of the different Mef2 splice variants for their ability to regulate expression level of miR-134.
A lack of effect on dmef2 expression level following exposure to PTX is indicative that this factor does not form a primary link between neuron membrane depolarization and altered expression of dpum. Our studies instead spotlight p300. p300 contains HAT activity and is also an accessory protein that interacts with other transcription factors to function as either a co-activator or as a repressor. For example, in Drosophila, p300 interacts with Dorsal, Mad and Cubitus interruptus, to co-activate Toll, decapentaplegic and Hedgehog signalling pathways, respectively (Akimaru et al., 1997a , Akimaru et al., 1997b , Waltzer & Bienz, 1999 . By contrast, T-cell factor (TCF)-mediated Wnt/Wingless signalling is repressed by p300 acetylation (Waltzer & Bienz, 1998) . In mammals, p300 has been reported to bridge the complex of thyroid hormone receptor-retinoid X receptor-Mef2A to abrogate transactivation of α-myosin heavy chain gene promoter activity when an inhibitor, adenovirus E1A for example, is recruited (De Luca et al., 2003) . Here we show p300 acts as a repressor of dMef2-mediated transactivation of dpum. We further show that this effect is likely achieved through direct binding of p300 to dMef2. This result mirrors the reported physical interaction between the cysteine/histidine-rich region 3 (CH3) domain of p300 and Mef2A/Mef2C (through MASD/Mef2 domains) in mammals (De Luca et al., 2003 , Sartorelli et al., 1997 .
Our results are consistent with increasing neuronal depolarization negatively regulating expression of p300 which, in turn, allows increased dMef2-mediated transactivation of dpum. Expression of p300 is known to be activity-dependent and is similarly downregulated in pilocarpine (increased acetylcholine signalling) treated mouse hippocampus (Hansen et al., 2014) . Expression of mef2 has also been reported to be regulated by increased synaptic excitation in mammals (Mao et al., 1999) , an observation we could not validate in Drosophila. We cannot rule out, however, that additional post-transcriptional and/or post-translational modifications, including alternative splicing and/or phosphorylation of dmef2 might influence its activity. In this regard, a report of Mef2 activation by Ca 2+ -activated dephosphorylation, via calcineurin, is particularly attractive (Flavell et al., 2006) . This is because Ca 2+ entry across the neuronal membrane is widely regarded as an initial reporter of neuronal activity in homeostatic mechanisms (Cudmore & Turrigiano, 2004 , Gunay & Prinz, 2010 , O'Leary et al., 2010 . Alternative post-transcriptional modifications of Mef2 activity have been reported. For example, p38 mitogen-activated protein kinase (p38-MAPK) induced phosphorylation of Mef2C is critical for activation of Mef2 target genes (Han et al., 1997 , Mao et al., 1999 .
Up-regulation of dpum transcript expression in late stage 17 Drosophila embryos, due to increased synaptic excitation, was previously reported (Mee et al., 2004) . Intriguingly, the analysis of transcript expression in 3 rd instar CNS between wildtype and wildtype raised on food containing the PTX revealed a significant reduction of dpum transcript expression (Lin et al., 2017) . These paradoxical results might be a result of dpum auto-regulation. The dpum transcript contains multiple PRE motifs in its 3'UTR region (Chen et al., 2008 , Gerber et al., 2006 . Similarly, human PUM1 and PUM2 are also potential targets of PUM protein (Bohn et al., 2018) . In this study, we used a dpum promoter to drive firefly-luc expression, which lacks PRE motifs, and showed enhanced dpum promoter activity in 3 rd instar larvae raised on food containing PTX. This result validates that the dpum promoter is responsive to levels of synaptic activity and also provides additional evidence to suggest that Pum regulates its own expression through negative-feedback.
In summary, we show that regulation of dpum expression is mediated by an interaction between dMef2 and p300, the latter being an activity-dependent negative regulator. Under 'normal' synaptic excitation, p300 is more abundant and binds to dMef2 to inhibit transactivation of dpum. Increased synaptic excitation reduces p300 expression which, in turn, releases dMef2 from inhibition. The increase in dPum protein translationally represses paralytic (voltage-gated sodium channel) mRNA to achieve a homeostatic reduction in action potential firing (the schematic mechanism is shown in Fig. 7) . It follows that inhibition of p300 would be predicted to be anticonvulsant (mirroring increased dPum activity). Indeed, treatments (genetic or pharmacological) that elevate dPum activity are potently anticonvulsive in Drosophila seizure mutants (Lin et al., 2017) . Moreover, seizures in flies, rodents and human are associated with a decrease in dPum or Pum2 activity, respectively (Follwaczny et al., 2017 , Lin et al., 2017 , Siemen et al., 2011 , Wu et al., 2015 . Thus, whilst drug interventions that directly active Pum may be difficult to achieve in the clinic, inhibition of p300 may represent a more achievable route to better control epilepsy.
Materials and Methods
Cloning of expression plasmids dpum promoter
Pumilio (dpum, CG9755) genomic sequence was obtained from FlyBase (http://flybase.org). Genomic DNA from Canton-S wildtype was extracted in 50 µl extraction buffer (10 mM Tris-HCl, 1 mM EDTA, 25 mM NaCl and 200 µg/ml proteinase K) with incubation at 37 o C for 30 min. Dpum promoter constructs were amplified by PCR (Phusion High-Fidelity DNA Polymerase, New England Biolabs, Hitchin, UK) that consisted of the following in a total volume of 50 µl: 20 pmol primers, dNTPs at 0.2 mM, and 1X Phusion HF buffer with 1.5 mM Mg
2+
. The forward and reverse primers introduced a Kpn I and a Xho I sites at the 5' and 3' end of promoter, respectively. Cycling conditions were: initial denaturation at 98°C for 5 min; 35 cycles of 98°C for 10 sec, 55°C for 20 sec and 72°C for 2 min 30 sec; a final extension step at 72°C for 10 min. The PCR product was digested with Kpn I and Xho I and ligated into pGL4.23 vector (Promega). The forward and reverse primer sequences are as follows (5' to 3'): pumA (-2000 to +1), AATAGGTACCCGATGGCTCCGGCGCTGA and pumR: TATTCTCGAGGAACATTTAGTGTGACCGCAGCT. A series of deletion constructs for the dpum promoter were PCR amplified using forward primers, pumB (-1434 to +1), AATAGGTACCGACCGTCGGCTGGATCCGT, pumC (-578 to +1), AATAGGTACCACATAGCTCGGAAAACGATTTCAAC, pumD (-312 to +1), ATATGGTACCATGGTTGTATTGATTCTTTATAT and pumE (-189 to +1), ATATGGTACCGGCAACTAGTTAAATGCATTATAG and the reverse primer, pumR.
Amplification of dmef2 splice variants and p300
Total RNA was extracted from 3 rd instar CNS of Canton-S. cDNA synthesis was carried out in a total volume of 20 µl using the manufacturer's protocol (RevertAid First-Strand cDNA Synthesis kit; Thermo Fisher Scientific). Dmef2 PCR was performed by using forward and reverse primers, which introduced a Kpn I and a Xho I site, respectively, and ligated to pAc5.1 expression vector (Thermo Fisher Scientific). Fifty-six plasmids from independent E. coli colonies were isolated and sequenced to identify splice variants of dmef2. The forward and reverse primer sequences are as follows (5' to 3'): ATTAGGTACCGGATAGGAAATCTGTTGCCATGG and ATTACTCGAGCAGCTCGTGCCGGCTATGT. p300 (nejire, CG15319) was PCRamplified with the primer pairs which introduced Kpn I and Xba I sites in the 5' and 3'
end of the open reading frame, respectively. PCR product was ligated to pAc5.1 expression vector. The forward and reverse primer sequences are as follows (5' to 3'): AATAGGTACCATGATGGCCGATCACTTAGACG and AATATCTAGACTAGAGTCGCTCCACAAACTTG. All clones were checked by sequencing prior to expression analysis.
Identification of transcription factor binding sites
Mouse and human pum2 promoter sequences (-2000 to +1) were obtained from the National Centre for Biotechnology Information (NCBI: https://www.ncbi.nlm.nih.gov), mouse: GRCm38:12: 8672314:8674133 and Human: NC_000002.12:c20354428-20352429. Transcriptional elements and factors were predicted using the TRANSFAC models of MAPPER search engine (http://genome.ufl.edu/mapper/). Mammalian transcription factors associated with human and mouse pum2 promoters were identified by the Harmonizome search engine (http://amp.pharm.mssm.edu/Harmonizome/).
Luciferase assay
S2R+ cells (10 6 cells in 100 μl of Schneider's Drosophila Medium, Gibco) were treated with dsRNA (1 μg) in a 96-well plate (Corning ® Costar ® ) for 3 h, followed by co-transfection (Effectene, QIAGEN) of dpum promoter-firefly construct and renilla luciferase reporter (100 ng each) for a further 24 h. The transfection procedure is as described in the manufacturer's instructions (QIAGEN). The luciferase assay was performed using the Dual-Luciferase reporter assay system (Promega). Briefly, 30 µl of transfected S2R+ cells were transferred to a well of a 96-well white plate (FluoroNunc TM ) and lysed with 30 µl of passive lysis buffer and then 30 µl Luciferase Assay Reagent II was added to measure firefly luciferase activity. This was followed by 30 µl of Stop & Glo ® to measure renilla luciferase activity. A GENios plate reader (TECAN) was used to measure luminescence. At least five independent transfections of each experiment were performed. Double-stranded RNA, dmef2 (BKN27383) and p300 (BKN21411), were obtained from the Sheffield RNAi Screening Facility (Sheffield, UK).
Luciferase activities of 3 rd instar larvae were measured using the Promega Steady-Glo Luciferase Assay Kit. Briefly, the dpum promoter-GAL4 line (see below for details) was crossed to attP24 UAS-luciferase flies (Markstein et al., 2008) . Flies carrying the UAS-luciferase transgene alone were used for background controls. Three larvae were collected in 200 µl Promega Glo Lysis buffer for each sample, and 10 independent samples collected for each genotype. Larvae were homogenized, incubated at room temperature for 10 min, centrifuged for 5 min, and supernatant was transferred to a new tube. For luciferase assays, 30 µl of each sample was transferred to a well of a white-walled 96-well plate at room temperature, 30 µl Promega Luciferase reagent was added to each well and plates were incubated in the dark for 10 min. Luminescence was measured with a GENios plate reader (TECAN). The obtained values were normalized to total protein concentration, measured using the Bradford protein assay (Bio-rad).
Quantitative RT-PCR
Quantitative RT-PCR was performed using a SYBR Green I real-time PCR method (Roche, LightCycler® 480 SYBR Green I Master, Mannheim, Germany) as described in Lin et al. (2015) . RNA was extracted from 20 3 rd instar CNSs using the RNeasy micro kit (QIAGEN, Hilden, Germany). PCR primers were designed with the aid of LightCycler Probe Design Software 2.0 (v1.0) (Roche). Primer sequences (5' to 3') used were: actin-5C (CG4027), CTTCTACAATGAGCTGCGT and GAGAGCACAGCCTGGAT; dmef2, TTCAAATATCACGCATCACCG and GCTGGCGTACTGGTACA; p300, GTTCTGGACTTCCCACG and TACTGGCTCATTTGCATGTAAC (forward and reverse, respectively). Relative gene expression was calculated as the 2 −ΔCt , where ΔCt was determined by subtracting the average actin-5C Ct value from that of dmef2 or p300.
Fly stocks
Transgenic flies were generated using the PhiC31 integrase-mediated transgenesis system. A pumC-GAL4-hsp70 fragment was constructed in the pattB vector and microinjected (BestGene Inc. Chino Hills, CA, USA) into an attP-containing fly stock (Bloomington Drosophila Stock Centre stock no. 9748: y 1 w 1118 ; PBac{y + -attP-3B}VK00031). UAS-p300 (stock no. 32573) and UAS-p300 F2161A (stock no. 32574) were obtained from Bloomington and UAS-p300
RNAi (stock no. 102885) was obtained from the Vienna Drosophila Resource Centre. The UAS-dmef2 was a gift from Dr. Michael Taylor (Cardiff University, Cardiff, UK). The attP24 UAS-luciferase stock was a gift from Dr. Norbert Perrimon (Howard Hughes Medical Institute, Boston, USA).
Yeast two-hybrid assay
Both p300 (bait) and dmef2 (prey) were cloned to pGBKT7 and pGADT7 vector, respectively. All yeast strains and plasmids (pGBKT7, pGADT7, pGBKT7-53, pGADT7-T and pGBKT7-Lam) were obtained from Clontech as components of the MATCHMAKER two-hybrid system 2. The Escherichia coli (E. coli) strain DH5α was used to clone every shuttle plasmid. Auxotrophic selection plates are Synthetic Dropout (SD) medium supplemented with 0.67% yeast nitrogen base, 0.06% appropriate dropout amino acid mixture and 2% bacto-agar. The purified bait and prey plasmids were co-transformed into the Y2HGold strain using a lithium-acetate method according to the manufacturer's instructions (Clontech) and were then cultured on SD/-Trp/-Leu agar plates. Approximately 2 mm of Y2HGold transformants were transferred to SD/-Trp/-Leu/-His/-Ade and SD/-Trp/-Leu/-His/-Ade/X-α-gal/Aureobasidin A plates at 30 °C for 2~3 d. The host Saccharomyces cerevisiae strain Y2HGold genotype is as follows : MATa, 112, gal4Δ, gal80Δ, LYS2 : : GAL1 UAS -Gal1 TATA -His3, GAL2 UASGal2 TATA -Ade2 URA3 : : MEL1 UAS -MEL1 TATA AUR1-C MEL1. In mammals, proteinprotein interaction between the cysteine-histidine-rich region 3 (CH3) domains containing C-terminus of p300 and Mef2A/Mef2C (through MASD/Mef2 domains) has been reported (De Luca et al., 2003 , Sartorelli et al., 1997 . Therefore, p300 (2976 amino acids, from 301 th to the end of C-terminus (3276 th )) and full length dMef2 were cloned. p300 bait, BD-p300 DNA fragment was released from p300/pAc5.1 using Nde I and Xba I (filling the sticky end to blunt end with Klenow) and ligating into pGBKT7 (Nde I and Sma I). dMef2 prey, AD-dmef2 DNA fragment was released from dmef2(VI)/pAc5.1 or dmef2(VII)/pAc5.1 using Kpn I (filling the sticky end to blunt end with Klenow) and Xho I and ligating into pGADT7 (BamH I (filling the sticky end to blunt end with Klenow) and Xho I).
Statistics
Statistical significance between group means was assessed using either a Student's ttest (where a single experimental group is compared to a single control group) or a one-way ANOVA followed by Bonferroni's post-hoc test (multiple experimental groups). Data shown is mean ± standard deviation (s. Activity analysis, by luciferase assays, of constructs bearing defined regions of a putative 2-kb dpum promoter that was placed upstream of firefly-luciferase (FF). These regions are termed pumA, pumB, pumC, pumD and pumE, respectively (-2000, -1434, -578, -312 and -189 to +1: transcription initiation marked as +1). Constructs were transiently co-transfected, together with a renilla-luciferase (Ren, a loading control, driven by actin promoter), in S2R+ cells for 24 h and pum:FF to Ren ratio was calculated. PumA, pumB, pumC, pumD and pumE:FF resulted in 156.5 ± 21.9, 164.8 ± 13.7, 159.8 ± 17.2, B Analysis of exon usage across the identified dmef2 splice variants shows that exon 10 is present at highest abundance (86%) followed by exon 14 (46%). A Shows expression of pumA promoter:firefly-luciferase (pumA:FF) reporter with individual dmef2 splice variants (dmef2(x)) and a renilla-luciferase gene (Ren, loading control, driven by actin promoter) in S2R+ cells. Expression of dmef2 variants resulted in a 1.6 ± 0.1 to 3.3 ± 0.2-fold increase in luciferase activity compared to control (CTRL, no dmef2 expression, set at 1) (n = 5 independent transfections).
B Shows the effectiveness of each splice variant ranked highest to lowest. Exon 10 containing variants, dmef2 (I, II, III, IV, VI and VII) , transactivated the dpum promoter to a greater level than variants lacking this exon: dmef2 (V, VIII, IX, X, XI and mini) . A dpum promoter:firefly-luciferase (pum:FF) constructs, containing different numbers of dMef2 binding motifs (pumA-E, 4, 3, 3, 2 and 0, respectively), were cotransfected with dmef2(VII) and a renilla-luciferase gene (Ren, loading control, driven by actin promoter) in S2R+ cells. Expression of dmef2 resulted in 1.9 ± 0.3, 1.7 ± 0.1, 1.4 ± 0.3, 1.4 ± 0.3 and 1.2 ± 0.1-fold increase in promoter activity (pumA-E, respectively) compared to control (set at 1: each construct expressed in the absence of dmef2(VII)) (n = 5 independent transfections).
B dPum protein activity can be measured using an actin promoter driven fireflyluciferase (FF) reporter gene containing Pumilio Response Elements (PRE) in the 3' UTR (FF-PRE). Increased dPum is sufficient, through binding the PREs and inhibiting translation, to reduce FF activity. An identical renilla-luciferase (Ren) reporter, but lacking the PRE sites (and thus not affected by dPum), is co-expressed to allow ratiometric determination of activity. Expression of dmef2(VI) or dmef2(VII) isoforms in S2R+ cells, that express both reporters, significantly reduces the ratio of FF-PRE/Ren to 0.7 ± 0.04 and 0.7 ± 0.21, respectively (control (CTRL), no dmef2 expression, set as 1) (n = 5 independent transfections).
Data information: Data are presented as mean ± s.d. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001. ns: not significant. (ANOVA with Bonferroni's post-hoc).
Figure 5 -p300 represses dMef2-mediated transactivation of the dpum promoter A The pumA promoter:firefly-luciferase (pumA:FF) reporter was co-transfected with p300 and a renilla-luciferase gene (Ren, loading control, driven by actin promoter) in S2R+ cells. Expression of p300 reduced pumA promoter activity to 0.76 ± 0.07, (control (CTRL), pumA:FF/Ren alone set at 1). By comparison, expression of dmef2(VII) resulted in a 2.14 ± 0.18-fold increase in luciferase activity compared to control. The activity of dmef2(VII) is abolished when co-expressed with p300 (0.75 ± 0.04). Pre-treatment of S2R+ cells with p300 dsRNA enhanced pumA promoter activity to 2.12 ± 0.22. Overexpression of dmef2, in the presence of p300 dsRNA, further increased pumA promoter activity to 4.41 ± 0.74 (n = 5 independent transfections).
B Co-transfection of pumA:FF with increasing doses of p300 showed a clear dosedependent suppression of dMef2(VII)-mediated transactivation (2.79 ± 0.22, 1.8 ± Figure 6 -dMef2 and p300 regulate dpum promoter activity in vivo Expression of dmef2, p300 or p300 F2161A , respectively, resulted in a 2.0 ± 0.3, 0.4 ± 0.2 and 0.3 ± 0.1-fold change in luciferase (luc) activity compared to control (pumCGAL4>luc cross with UAS-GFP (GFP), set at 1). Knock-down of p300 expression, achieved by crossing UAS-p300
RNAi (p300
RNAi
), resulted in a 1.3 ± 0.4-fold increase in luc activity (n = 10 independent sample collections).
Data information: data are presented as mean ± s.d. *P ≤ 0.05 and ***P ≤ 0.001. (ANOVA with Bonferroni's post-hoc).
Figure 7 -Transcription of dpum is co-regulated by dMef2 and p300
A Under 'normal' synaptic excitation, p300 is more abundant and binds to dMef2 to inhibit the transactivation of dpum.
B Increasing exposure to synaptic excitation is sufficient to downregulate expression of p300 resulting in the release of dMef2 from inhibition. This facilitates transactivation of dpum. Increased dPum protein can, in turn, translationally repress paralytic mRNA (para; voltage-gated sodium channel) to achieve a homeostatic reduction in action potential firing. 
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